ICLR
ICON Public Limited CompanyNASDAQHealthcare$114.19+2.49%ClosedMarket Cap: $8.72B
As of 2026-04-06
Valuation
P/E (TTM)
14.55
PEG
—
P/B
0.95
P/S
1.08
EV/EBITDA
10.03
DCF Value
$297.53
FCF Yield
11.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
26.9%
Operating Margin
12.2%
Net Margin
7.4%
ROE
6.3%
ROA
14.3%
ROIC
6.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $2.04B | 22.3% | $258.9M | $2.4M | $0.03 | — |
| Q2 2025 | $2.02B | 27.8% | $209.2M | $183.0M | $2.30 | — |
| Q1 2025 | $2.00B | 27.9% | $219.6M | $154.2M | $1.90 | — |
| Q4 2024 | $2.04B | 29.4% | $297.0M | $260.0M | $3.16 | — |
| FY 2024 | $8.28B | 29.4% | $1.10B | $791.5M | $9.53 | — |
| Q3 2024 | $2.03B | 29.1% | $285.4M | $197.1M | $2.36 | — |
| Q2 2024 | $2.12B | 29.6% | $229.9M | $146.9M | $1.76 | — |
| Q1 2024 | $2.09B | 29.6% | $285.5M | $187.4M | $2.25 | — |
| Q4 2023 | $2.07B | 30.0% | $265.6M | $216.4M | $2.60 | — |
| FY 2023 | $8.12B | 29.6% | $956.2M | $612.3M | $7.40 | — |
| Q3 2023 | $2.06B | 29.5% | $264.3M | $163.7M | $1.97 | — |
| Q2 2023 | $2.02B | 29.2% | $209.5M | $115.6M | $1.40 | — |